249 related articles for article (PubMed ID: 19269969)
1. Silencing of D4-GDI inhibits growth and invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signaling.
Zhang Y; Rivera Rosado LA; Moon SY; Zhang B
J Biol Chem; 2009 May; 284(19):12956-65. PubMed ID: 19269969
[TBL] [Abstract][Full Text] [Related]
2. D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness.
Zhang Y; Zhang B
Cancer Res; 2006 Jun; 66(11):5592-8. PubMed ID: 16740694
[TBL] [Abstract][Full Text] [Related]
3. Mutated D4-guanine diphosphate-dissociation inhibitor is found in human leukemic cells and promotes leukemic cell invasion.
Nakata Y; Kondoh K; Fukushima S; Hashiguchi A; Du W; Hayashi M; Fujimoto J; Hata J; Yamada T
Exp Hematol; 2008 Jan; 36(1):37-50. PubMed ID: 18037226
[TBL] [Abstract][Full Text] [Related]
4. Cloning and characterization of bovine low molecular weight GTPases (Rac1 and Rac2) and rho GDP-dissociation inhibitor 2 (D4-GDI).
Davis AR; Clements MK; Bunger PL; Siemsen DW; Quinn MT
Vet Immunol Immunopathol; 2000 May; 74(3-4):285-301. PubMed ID: 10802295
[TBL] [Abstract][Full Text] [Related]
5. Altered cellular immunity in transgenic mice with T cell-specific expression of human D4-guanine diphosphate-dissociation inhibitor (D4-GDI).
Kondoh K; Nakata Y; Yamaoka T; Itakura M; Hayashi M; Yamada K; Hata J; Yamada T
Int Immunol; 2008 Oct; 20(10):1299-311. PubMed ID: 18689726
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of NADPH oxidase activation by the Rac/Rho-GDI complex.
Di-Poï N; Fauré J; Grizot S; Molnár G; Pick E; Dagher MC
Biochemistry; 2001 Aug; 40(34):10014-22. PubMed ID: 11513579
[TBL] [Abstract][Full Text] [Related]
7. Silencing Ras-Related C3 Botulinum Toxin Substrate 1 Inhibits Growth and Migration of Hypopharyngeal Squamous Cell Carcinoma via the P38 Mitogen-Activated Protein Kinase Signaling Pathway.
Cheng H; Wang W; Wang G; Wang A; Du L; Lou W
Med Sci Monit; 2018 Feb; 24():768-781. PubMed ID: 29410394
[TBL] [Abstract][Full Text] [Related]
8. RhoGDIα-dependent balance between RhoA and RhoC is a key regulator of cancer cell tumorigenesis.
Giang Ho TT; Stultiens A; Dubail J; Lapière CM; Nusgens BV; Colige AC; Deroanne CF
Mol Biol Cell; 2011 Sep; 22(17):3263-75. PubMed ID: 21757538
[TBL] [Abstract][Full Text] [Related]
9. Differential properties of D4/LyGDI versus RhoGDI: phosphorylation and rho GTPase selectivity.
Gorvel JP; Chang TC; Boretto J; Azuma T; Chavrier P
FEBS Lett; 1998 Jan; 422(2):269-73. PubMed ID: 9490022
[TBL] [Abstract][Full Text] [Related]
10. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells.
Baugher PJ; Krishnamoorthy L; Price JE; Dharmawardhane SF
Breast Cancer Res; 2005; 7(6):R965-74. PubMed ID: 16280046
[TBL] [Abstract][Full Text] [Related]
11. Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases.
Moissoglu K; McRoberts KS; Meier JA; Theodorescu D; Schwartz MA
Cancer Res; 2009 Apr; 69(7):2838-44. PubMed ID: 19276387
[TBL] [Abstract][Full Text] [Related]
12. Association of D4-GDI expression with breast cancer progression.
Rivera Rosado LA; Rodriguez-Canales J; Zhang B
Cancer Biomark; 2011-2012; 10(3-4):163-73. PubMed ID: 22674302
[TBL] [Abstract][Full Text] [Related]
13. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
Boissier P; Huynh-Do U
Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
[TBL] [Abstract][Full Text] [Related]
14. D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis.
Na S; Chuang TH; Cunningham A; Turi TG; Hanke JH; Bokoch GM; Danley DE
J Biol Chem; 1996 May; 271(19):11209-13. PubMed ID: 8626669
[TBL] [Abstract][Full Text] [Related]
15. Assessment of roles for the Rho-specific guanine nucleotide dissociation inhibitor Ly-GDI in platelet function: a spatial systems approach.
Ngo AT; Thierheimer ML; Babur Ö; Rocheleau AD; Huang T; Pang J; Rigg RA; Mitrugno A; Theodorescu D; Burchard J; Nan X; Demir E; McCarty OJ; Aslan JE
Am J Physiol Cell Physiol; 2017 Apr; 312(4):C527-C536. PubMed ID: 28148498
[TBL] [Abstract][Full Text] [Related]
16. Regulation of anoikis by Cdc42 and Rac1.
Cheng TL; Symons M; Jou TS
Exp Cell Res; 2004 May; 295(2):497-511. PubMed ID: 15093747
[TBL] [Abstract][Full Text] [Related]
17. RhoGDI-3 is a new GDP dissociation inhibitor (GDI). Identification of a non-cytosolic GDI protein interacting with the small GTP-binding proteins RhoB and RhoG.
Zalcman G; Closson V; Camonis J; Honoré N; Rousseau-Merck MF; Tavitian A; Olofsson B
J Biol Chem; 1996 Nov; 271(48):30366-74. PubMed ID: 8939998
[TBL] [Abstract][Full Text] [Related]
18. Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis.
Zhang B; Zhang Y; Dagher MC; Shacter E
Cancer Res; 2005 Jul; 65(14):6054-62. PubMed ID: 16024605
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 is a target gene of rho GDP dissociation inhibitor beta in breast cancer cells.
Schunke D; Span P; Ronneburg H; Dittmer A; Vetter M; Holzhausen HJ; Kantelhardt E; Krenkel S; Müller V; Sweep FC; Thomssen C; Dittmer J
Cancer Res; 2007 Nov; 67(22):10694-702. PubMed ID: 18006811
[TBL] [Abstract][Full Text] [Related]
20. Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration.
Cushman I; Casey PJ
J Biol Chem; 2009 Oct; 284(41):27964-27973. PubMed ID: 19651782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
